Medi Assist Healthcare Services Limited (BOM:544088)
India · Delayed Price · Currency is INR 360.95
+4.70 (1.32%)
At close: Aug 21, 2026
BOM:544088 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 26,949 | 22,140 | 32,095 | 35,501 | - | - | |
Market Cap Growth | -29.26% | -31.02% | -9.59% | - | - | - |
Enterprise Value | 25,237 | 23,201 | 29,440 | 35,012 | - | - |
Last Close Price | 360.95 | 296.90 | 454.50 | 502.33 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 28.92 | 25.19 | 35.32 | 53.04 | - | - |
PS Ratio | 2.83 | 2.45 | 4.44 | 5.59 | - | - |
PB Ratio | 3.16 | 2.60 | 5.81 | 7.38 | - | - |
P/TBV Ratio | 9.84 | 8.08 | 10.17 | 12.82 | - | - |
P/FCF Ratio | 43.36 | 35.63 | 34.78 | 74.02 | - | - |
P/OCF Ratio | 22.82 | 18.75 | 23.24 | 53.48 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.65 | 2.56 | 4.07 | 5.52 | - | - |
EV/EBITDA Ratio | 13.59 | 13.29 | 23.49 | 31.00 | - | - |
EV/EBIT Ratio | 26.36 | 23.80 | 29.55 | 38.69 | - | - |
EV/FCF Ratio | 40.61 | 37.33 | 31.90 | 73.00 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.06 | 0.06 | 0.37 | 0.06 | 0.08 | 0.08 |
Debt / EBITDA Ratio | 0.29 | 0.31 | 1.46 | 0.21 | 0.26 | 0.31 |
Debt / FCF Ratio | - | 0.88 | 2.21 | 0.55 | 0.57 | 0.47 |
Net Debt / Equity Ratio | -0.22 | -0.22 | -0.44 | -0.43 | -0.55 | -0.65 |
Net Debt / EBITDA Ratio | -0.99 | -1.06 | -1.93 | -1.82 | -1.98 | -2.83 |
Net Debt / FCF Ratio | - | -2.97 | -2.62 | -4.29 | -3.96 | -3.81 |
Asset Turnover | - | 0.72 | 0.72 | 0.82 | 0.77 | 0.69 |
Quick Ratio | - | 1.20 | 1.40 | 1.37 | 1.42 | 1.65 |
Current Ratio | - | 1.34 | 1.49 | 1.50 | 1.59 | 1.81 |
Return on Equity (ROE) | - | 12.72% | 17.73% | 16.48% | 20.83% | 20.09% |
Return on Assets (ROA) | - | 4.81% | 6.20% | 7.27% | 8.91% | 6.94% |
Return on Invested Capital (ROIC) | 14.34% | 19.94% | 27.87% | 34.14% | 46.85% | 40.03% |
Return on Capital Employed (ROCE) | - | 10.40% | 15.20% | 17.00% | 21.80% | 17.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.46% | 3.97% | 2.83% | 1.89% | - | - |
FCF Yield | 2.31% | 2.81% | 2.88% | 1.35% | - | - |
Dividend Yield | 0.55% | 0.67% | - | 0.80% | - | - |
Payout Ratio | - | - | 30.96% | 19.44% | 17.57% | 26.81% |
Buyback Yield / Dilution | -3.99% | -2.28% | -0.83% | -0.95% | -0.18% | -2.60% |
Total Shareholder Return | -3.44% | -1.60% | -0.83% | -0.16% | -0.18% | -2.60% |